Marlene F Shehata | OMICS International
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google Scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Marlene F Shehata

Clinical Pharmacist Consultant/Cardiovascular Geneticist, Ottawa ON, Canada


Dr. Shehata M is currently affiliated to Expertise, Clinical Pharmacist Consultant/Cardiovascular Geneticist Marlene Shehata Pharmaceuticals, Ottawa, Ontario, Canada and continuing research in the specialized scientific area of cardiovascular genetics. Dr. Shehata M extended his valuable service for many years and has been a recipient of many award and grants. Her international experience includes various programs, contributions and participation in different countries for diverse fields of study.

Human Papillomavirus (HPV) Vaccine: Is it worthwhile?

Cervical cancer is one of the most common cancers in women. Human Papillomavirus (HPV) is the primary cause of cervical, anal, vulvar, vaginal and penile cancers as well as genital warts. Over 120 types of HPV have been isolated with more than 40 of these types infecting the epithelial lining of the anal and genital tracts [6]. HPV infections can b... Read More»

Marlene F Shehata and Alan Pater

Editorial: J Biotechnol Biomaterial 2011, 1:103e

DOI: 10.4172/2155-952X.1000103e

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article